S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.21%)
T   16.80 (+1.27%)
F   12.14 (+0.17%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.44 (+0.45%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Genetic Technologies (GENE) Short Interest Ratio & Short Volume

$1.95
+0.00 (+0.17%)
(As of 12:49 PM ET)

Genetic Technologies Short Interest Data

Current Short Volume
29,100 shares
Previous Short Volume
28,100 shares
Change Vs. Previous Month
+3.56%
Dollar Volume Sold Short
$57,909.00
Short Interest Ratio / Days to Cover
1.2
Last Record Date
January 31, 2024
Outstanding Shares
3,850,000 shares
Percentage of Shares Shorted
0.76%
Today's Trading Volume
2,026 shares
Average Trading Volume
15,717 shares
Today's Volume Vs. Average
13%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Genetic Technologies ?

Sign up to receive the latest short interest report for Genetic Technologies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GENE Short Interest Over Time

GENE Days to Cover Over Time

GENE Percentage of Float Shorted Over Time


Genetic Technologies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202429,100 shares $57,909.00 +3.6%N/A1.2 $1.99
1/15/202428,100 shares $66,878.00 +19.6%N/A1.2 $2.38
12/31/202323,500 shares $56,400.00 -19.8%N/A0.9 $2.40
12/15/202329,300 shares $87,314.00 -80.2%N/A1.3 $2.98
11/30/2023147,800 shares $539,543.90 -25.4%N/A1.2 $3.65
11/15/2023198,200 shares $139,889.56 -34.2%N/A1.8 $0.71
10/31/2023301,100 shares $213,449.79 +89.7%N/A2.6 $0.71
10/15/2023158,700 shares $107,550.99 -14.0%N/A1.3 $0.68
9/30/2023184,500 shares $140,699.70 -50.0%N/A1.8 $0.76
9/15/2023368,600 shares $319,760.50 +469.7%N/A3.4 $0.87
8/31/202364,700 shares $51,760.00 +22.3%N/A1 $0.80
8/15/202352,900 shares $37,559.00 -61.8%N/A0.6 $0.71
7/31/2023138,300 shares $116,172.00 -14.7%N/A1.3 $0.84
7/15/2023162,100 shares $148,045.93 +54.1%N/A1.4 $0.91
6/30/2023105,200 shares $87,400.16 +7.6%N/A0.9 $0.83
6/15/202397,800 shares $96,333.00 -53.7%N/A0.8 $0.99
5/31/2023211,200 shares $202,287.36 +161.7%N/A1.5 $0.96
5/15/202380,700 shares $76,665.00 No ChangeN/A0.4 $0.95
10/31/202269,800 shares $83,411.00 -14.8%N/A1.5 $1.20
10/15/202281,900 shares $95,823.00 +21.7%N/A1.5 $1.17
9/30/202267,300 shares $78,599.67 -20.9%N/A1.1 $1.17
9/15/202285,100 shares $128,501.00 +66.2%N/A1.1 $1.51
8/31/202251,200 shares $75,264.00 +16.9%N/A0.7 $1.47
8/15/202243,800 shares $72,270.00 +8.4%N/A0.6 $1.65
7/31/202240,400 shares $64,640.00 -15.0%N/A0.6 $1.60
7/15/202247,500 shares $68,875.00 -22.4%N/A0.8 $1.45
6/30/202261,200 shares $70,992.00 -13.6%N/A1.1 $1.16
6/15/202270,800 shares $80,004.00 -17.2%N/A1.4 $1.13
5/31/202285,500 shares $107,105.85 -21.2%N/A1.5 $1.25
5/15/2022108,500 shares $133,455.00 -19.6%N/A1.5 $1.23
4/30/2022134,900 shares $211,793.00 -12.8%N/A1.9 $1.57
4/15/2022154,700 shares $280,007.00 -23.4%N/A2.1 $1.81
3/31/2022202,000 shares $397,940.00 -38.2%N/A2.6 $1.97
3/15/2022326,600 shares $604,210.00 -6.9%N/A3.5 $1.85
2/28/2022350,900 shares $726,363.00 +23.5%N/A2.5 $2.07
2/15/2022284,200 shares $582,610.00 -11.2%N/A2 $2.05
1/31/2022320,200 shares $595,572.00 -0.5%N/A2.3 $1.86
1/15/2022321,700 shares $598,362.00 -4.8%N/A2.3 $1.86
12/31/2021337,900 shares $635,252.00 -14.2%N/A2.4 $1.88
12/15/2021393,800 shares $823,042.00 +17.2%N/A2.7 $2.09













GENE Short Interest - Frequently Asked Questions

What is Genetic Technologies' current short interest?

Short interest is the volume of Genetic Technologies shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 29,100 shares of GENE short. Learn More on Genetic Technologies' current short interest.

What is a good short interest ratio for Genetic Technologies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GENE shares currently have a short interest ratio of 1.0. Learn More on Genetic Technologies's short interest ratio.

Which institutional investors are shorting Genetic Technologies?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Genetic Technologies: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Genetic Technologies' short interest increasing or decreasing?

Genetic Technologies saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 29,100 shares, an increase of 3.6% from the previous total of 28,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Genetic Technologies' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Genetic Technologies: Eiger BioPharmaceuticals, Inc. (2.54%), Creative Medical Technology Holdings, Inc. (1.70%), Titan Pharmaceuticals, Inc. (0.96%), TRACON Pharmaceuticals, Inc. (3.92%), Fresh Tracks Therapeutics, Inc. (0.17%), NanoString Technologies, Inc. (12.55%), Organovo Holdings, Inc. (3.13%), Avalon GloboCare Corp. (1.14%), Palisade Bio, Inc. (25.67%), Finch Therapeutics Group, Inc. (0.38%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Genetic Technologies stock?

Short selling GENE is an investing strategy that aims to generate trading profit from Genetic Technologies as its price is falling. GENE shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genetic Technologies?

A short squeeze for Genetic Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GENE, which in turn drives the price of the stock up even further.

How often is Genetic Technologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GENE, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:GENE) was last updated on 2/23/2024 by MarketBeat.com Staff